Coltsfoot for Cough: The Tradition and the Evidence

Read the liver page first. Coltsfoot contains hepatotoxic pyrrolizidine alkaloids, and nothing on this page changes that; see Coltsfoot and Pyrrolizidine Alkaloids: The Liver Risk. This page exists because the other half of the story is also real and deserves documenting properly: coltsfoot has one of the longest, most specific cough reputations of any plant in the European and Chinese herbal canons, and its soothing effect has a physically sensible explanation.

What this page will not do is let the tradition carry more weight than it can bear. Two thousand years of use tells you that people found something worth repeating. It does not tell you the plant outperformed a hot drink, a spoon of honey, or the simple passage of time — and in coltsfoot's case, nobody has done the trial that would tell us. So this is a page about a deep tradition, a plausible mechanism, some interesting laboratory pharmacology, and a controlled-trial cupboard that is essentially bare.

The Name Is the Claim
Dioscorides, Pliny and Medicinal Smoke
Kuan Dong Hua in Chinese Medicine
Coltsfoot Rock, Syrups and Herbal Tobacco
The Demulcent Mechanism: Why Mucilage Soothes
Tussilagone and the Laboratory Pharmacology
Animal Antitussive Work: What It Shows
The Human Trial Evidence: Essentially Absent
Why Tradition Cannot Carry This Weight
What a Cough Does on Its Own
The Effect Is Real but Interchangeable
When a Cough Needs a Clinician
Evidence Tiers for Every Claim
Key Research Papers
Connections

The Name Is the Claim

Very few plants wear their indication in their scientific name. Coltsfoot does. Tussilago is built from the Latin tussis, "cough," and agere, "to drive away" — the cough dispeller. The species epithet farfara is thought to derive from an old Latin word for the mealy, whitish underside of the leaf. Linnaeus did not invent the association in the eighteenth century; he inherited a name already worn smooth by centuries of use.

The English name records the leaf rather than the use: the broad, hoof-shaped leaves resemble a colt's foot. Old country names record the plant's odd habit of flowering before it leafs — "son-before-father" — because the bright yellow flower heads push through bare or frozen ground in very early spring, sometimes while snow lingers, and the leaves follow weeks later. The Chinese name for the medicinal flower bud, kuan dong hua (款冬花), points at the same trait: a flower of the cold season.

Two independent naming traditions, on opposite ends of Eurasia, converging on the same plant for the same purpose, is a genuinely striking piece of ethnobotanical evidence. It is worth taking seriously as a signal that people reliably experienced something. It is not, on its own, evidence of efficacy — a point we return to below, because it is where herbal reasoning most often goes wrong.

Dioscorides, Pliny and Medicinal Smoke

Coltsfoot appears in the two foundational works of classical Western pharmacy. Dioscorides, the Greek physician whose De Materia Medica shaped European herbalism for a millennium and a half, described it; so did Pliny the Elder in his Natural History. Both recommended something that startles modern readers: smoking the dried leaves to relieve a stubborn cough, drawing the smoke in through a reed.

That places coltsfoot among the classical "medicinal smoke" herbs — a practice long predating tobacco's arrival in Europe. The logic, from the humoral framework of the time, was that a dry or obstinate cough involved stuck phlegm in the chest and that warm, penetrating smoke could loosen and expel it. From a modern standpoint, inhaled smoke of any kind irritates the airway and provokes coughing, which can transiently clear secretions and then leave the airway feeling clearer — a real sensation with a mechanism, but not a treatment we would recommend. Inhaling combustion products is not a rational delivery route, and it does not avoid the plant's alkaloids either.

Through the medieval and early modern herbals coltsfoot kept its narrow, specific reputation: not a cure-all, but a chest herb. Culpeper and the later English herbalists list it for coughs, wheezing, hoarseness and "shortness of breath." That consistency of indication over centuries is unusual — many traditional herbs accumulate an indiscriminate list of uses, and coltsfoot largely did not. (Evidence tier: traditional use only.)

Kuan Dong Hua in Chinese Medicine

In traditional Chinese medicine the material used is the unopened flower bud, harvested before the flower opens and prepared either dried or, more often, honey-fried (mi zhi kuan dong hua). Honey-frying is a standard processing method (pao zhi) applied to several lung herbs; the stated intent is to moisten, to soften harshness and to direct the herb's action downward, quieting cough rather than stimulating expectoration.

In the classical framework kuan dong hua is warm and slightly bitter, and it enters the Lung channel. Its indications are cough with copious phlegm, wheezing, and cough of long standing including cough with blood-streaked sputum. It is rarely used alone. It is classically paired with zi wan (Aster tataricus root) — the two are considered a near-inseparable couplet for cough — and appears in multi-herb formulas alongside apricot kernel, loquat leaf, ophiopogon and licorice.

Two observations matter for a reader trying to weigh this. First, the traditional Chinese use is polyherbal: the tradition does not claim coltsfoot alone stops a cough, and testing single herbs against that tradition is a category slip in both directions. Second, and important for safety, the flower bud is the plant part more likely to be alkaloid-rich, and honey-frying has not been shown to remove pyrrolizidine alkaloids. The most traditional Chinese preparation is therefore not the safest one, and honey-frying should not be read as a detoxification step. (Evidence tier: traditional use only; the alkaloid point is established analytical chemistry.)

Coltsfoot Rock, Syrups and Herbal Tobacco

Coltsfoot's European afterlife is unusually domestic, and it is a small window into how a medicine becomes a habit.

Coltsfoot rock. A hard, brittle, faintly liquorice-tasting English confection, still made in parts of northern England, historically flavoured with coltsfoot extract and sold as much as a sweet as a remedy.
Coltsfoot syrup and lozenges. The standard nineteenth-century pharmacy form: leaf or flower decoction with sugar or honey. Much of the perceived benefit here belongs to the sugar syrup itself, which coats the pharynx and triggers salivation and swallowing — a genuine, measurable antitussive effect that any syrup shares.
British Herbal Tobacco. A commercial smoking mixture in which coltsfoot was the principal ingredient, sold well into the twentieth century for bronchitis and asthma and as a tobacco substitute.
Coltsfoot wine and beer. Country recipes for the spring flowers, more seasonal pleasure than medicine.

The confectionery history is quietly informative. When a remedy migrates into sweets, the sweetness is doing work — and the sugar-syrup effect is one of the best documented mechanisms in the whole cough field. It is a reasonable inference that a fair share of coltsfoot's historical reputation was carried by the vehicle it came in. (Evidence tier: traditional use, plus established pharmacology of sugar-syrup demulcents in general.)

The Demulcent Mechanism: Why Mucilage Soothes

Here is the part of coltsfoot's reputation that has a real, physical explanation, and it deserves to be stated generously before it is put in perspective.

Coltsfoot leaves and flowers are rich in mucilage — long-chain polysaccharides that absorb water and swell into a viscous gel. Herbs high in mucilage are called demulcents, and what they do is straightforward: sipped as a warm infusion, the gel spreads as a thin film over the mucosa of the pharynx and upper airway.

Why that eases a cough involves a little neurophysiology. Cough is a reflex, driven substantially by sensory nerve endings in the airway lining that respond to irritation — mechanical, chemical, inflammatory. In an upper respiratory infection those endings are exposed and sensitised, so trivial stimuli that would normally pass unnoticed trigger a cough, which further irritates the tissue, which lowers the threshold again. That self-sustaining loop is what people mean by a "tickly" cough.

A demulcent interrupts the loop at the periphery in at least three ways:

Physical barrier. The mucilage film sits between irritants and sensitised nerve endings.
Hydration. A viscous, water-holding layer keeps a dried, inflamed surface moist, and dryness is itself a cough trigger.
Reflex salivation and swallowing. Sweet, viscous material in the pharynx provokes salivation and swallowing, which appear to inhibit the cough reflex centrally — the same mechanism credited with much of the effect of honey and of sugar-based cough syrups.

This is real pharmacology, not hand-waving, and it explains why demulcent teas feel good within a minute of drinking them. But notice its nature: it is non-specific. It is a property of mucilage and of warm sweet fluid, not a property of Tussilago farfara. Anything with comparable mucilage does the same job — marshmallow root, whose mucilage content is higher, slippery elm, mullein, plantain leaf, and plain honey in warm water. None of them contains a hepatotoxic alkaloid. (Evidence tier: established mechanism for demulcents as a class; not demonstrated in a controlled trial for coltsfoot specifically.)

Tussilagone and the Laboratory Pharmacology

Coltsfoot's chemistry is genuinely interesting, and the modern review of the plant — A review of the ethnobotanical value, phytochemistry, pharmacology, toxicity and quality control of Tussilago farfara L. (coltsfoot), Journal of Ethnopharmacology, 2021 — catalogues well over a hundred identified constituents. Several classes are relevant to a respiratory claim:

Mucilage polysaccharides — the demulcent fraction described above.
Flavonoids, notably rutin and hyperoside, with antioxidant and anti-inflammatory activity in cell systems.
Sesquiterpenoids, above all tussilagone, the plant's signature compound and the one that has drawn most pharmacological attention.
Phenolic acids, including chlorogenic-acid derivatives.
Pyrrolizidine alkaloids — senkirkine and senecionine, present in the same material.

Tussilagone has been studied in cell and animal models for several actions. Reported findings include anti-inflammatory activity in macrophages — the 2009 study The anti-inflammatory effect of tussilagone, from Tussilago farfara, is mediated by the induction of heme oxygenase-1 in murine macrophages, in International Immunopharmacology, showed suppression of inflammatory signalling through induction of the protective enzyme heme oxygenase-1. Other laboratory work has reported antagonism of platelet-activating factor, a mediator relevant to airway inflammation, and older Chinese pharmacological work described tussilagone as a cardiovascular and respiratory stimulant in animals — a pressor effect that is pharmacologically real and, notably, not obviously desirable in a cough remedy.

Three cautions about how far this can be pushed, and they apply to laboratory pharmacology generally:

These are isolated-compound, cell-and-animal findings. "Suppresses inflammatory signalling in cultured macrophages" is several long steps from "relieves a human cough."
Concentrations used in vitro often exceed what a tea could deliver to tissue. A cell bathed in a defined concentration is not a pharynx briefly wetted by an infusion.
Isolating the interesting compound does not isolate away the alkaloid. A purified tussilagone preparation would be a different product from coltsfoot tea, and nobody is selling one.

(Evidence tier: preliminary — in-vitro and animal only.)

Animal Antitussive Work: What It Shows

There is animal work on coltsfoot extracts and cough. The standard designs use chemically induced cough in guinea pigs or mice — typically citric-acid or ammonia aerosol — and count coughs, or use tracheal phenol-red output as a crude proxy for expectoration. Extracts of Tussilago farfara have been reported to reduce cough counts and to affect airway secretion in such models.

These studies are worth knowing about, and they are worth not over-reading. Their well-recognised limitations:

Induced cough is not infectious cough. A citric-acid aerosol provokes a reflex in a healthy animal; it does not reproduce a virally inflamed, sensitised human airway.
The doses are often high relative to human use, and given by gavage.
Positive results are near-universal in this literature. A great many plant extracts reduce cough counts in these models, which limits how much any single positive result distinguishes a herb.
Publication and reporting practices in this specific literature tend to favour positive findings, and blinding is frequently unreported.

Honest summary: the animal work is consistent with a mild antitussive or secretion-modifying action and does not establish a clinically meaningful one in people. (Evidence tier: preliminary — animal models.)

The Human Trial Evidence: Essentially Absent

This is the section that ought to be longest and instead has to be shortest, and that fact is the finding.

There is no adequate randomised controlled trial of coltsfoot for cough in humans. Not a negative trial — an absent one. Search the literature for controlled clinical evaluation of Tussilago farfara as an antitussive and you find reviews describing traditional use, phytochemical analyses, toxicological studies, animal pharmacology and case reports of liver injury. What you do not find is the study design that would answer the question: a randomised, placebo-controlled trial in people with acute cough, with cough frequency or severity as a pre-specified outcome, of adequate size.

Contrast that with what does exist elsewhere in the same therapeutic space, and the gap becomes stark:

Honey has multiple randomised trials in childhood nocturnal cough and has been assessed in Cochrane reviews. See Honey: Cough Suppressant Evidence.
Ivy leaf extract and Pelargonium sidoides extract have been evaluated in randomised trials in acute bronchitis and are licensed as herbal medicines in parts of Europe on that basis.
Thyme-and-primrose combinations have randomised trial data in acute bronchitis.

Those comparators matter because they demolish the usual defence of an evidence gap. "It is a traditional herb, nobody funds trials of traditional herbs" is not true here: trials of traditional cough herbs exist, several have been run to a decent standard, and the reason coltsfoot is not among them is not that the field is uninterested in herbs. It is more plausibly that no European regulator would license an internal coltsfoot product, so there is no commercial route that a trial could serve — see Regulation, Bans and "PA-Free" Products. The absence of trials and the presence of restrictions are the same fact seen from two sides.

(Evidence tier: no randomised controlled trial evidence in humans. This is a statement about the literature, not a claim that the herb was tested and failed.)

Why Tradition Cannot Carry This Weight

Long use is genuine information. It is a filter: a plant that made people acutely, obviously ill tended to fall out of use, and a plant that seemed to help got repeated. That is why traditional pharmacopoeias are a rational place to look for candidate medicines, and why dismissing them wholesale is bad reasoning.

But the filter has known blind spots, and coltsfoot happens to sit in all three:

Tradition cannot separate a remedy from natural recovery. Almost every acute cough resolves. A remedy taken during recovery is credited with it — reliably, across centuries, by intelligent people. This is the single largest source of false positives in the entire history of medicine.
Tradition cannot detect delayed, cumulative harm. This is the decisive blind spot for coltsfoot. Pyrrolizidine-alkaloid liver injury may appear weeks or months after exposure, in a small proportion of users, presenting as abdominal swelling and jaundice. No pre-modern observer could have connected that to a springtime tea drunk months earlier. A tradition's safety record is only as good as its ability to see the harm — and this harm was structurally invisible.
Tradition cannot compare like with like. Nobody in 1650 could ask whether coltsfoot beat marshmallow root, or beat warm honey water. The question requires randomisation and a control group.

So the correct reading of coltsfoot's two-thousand-year record is: people consistently found that a warm, sweet, slippery drink soothed their throats, and coltsfoot was one of the plants that provided one. That is a fair claim. It is also fully satisfied by plants that carry no liver toxin.

What a Cough Does on Its Own

To judge any cough remedy you need to know the shape of the untreated illness, because that shape is what fools people.

Acute cough after a common cold typically peaks in the first few days and then declines over one to three weeks. A substantial minority of people still have some cough at three weeks; a smaller group runs longer, and post-infectious cough lasting six to eight weeks is well recognised and usually benign. The important feature is that the trajectory is downward on its own, and it is often bumpy — a bad night followed by two better ones.

Now add the placebo response, which in cough studies is unusually large. Cough is measured largely by self-report, expectation strongly modulates symptom perception, and any pleasant intervention performs respectably. In trials of cough medicines the placebo arm routinely improves substantially. This is exactly why an uncontrolled impression — yours, or a seventeenth-century herbalist's — cannot distinguish a real drug effect from a downward trajectory plus a warm drink plus expectation.

None of this means the relief is imaginary. Comfort is a legitimate goal in a self-limiting illness, and if a warm demulcent tea makes a rotten week more bearable, that is worth having. The point is narrower and it is decisive: if the benefit you are buying is comfort, buy it from a herb with no liver toxin.

The Effect Is Real but Interchangeable

Putting the strands together, here is the honest position on coltsfoot for cough:

Coltsfoot's soothing effect on a dry, tickly cough is plausible and probably real, via mucilage acting as a demulcent. (Mechanism established for demulcents as a class.)
It has additional laboratory pharmacology — anti-inflammatory tussilagone, flavonoids — that is scientifically interesting. (Preliminary; in-vitro and animal.)
It has animal antitussive data consistent with a mild effect. (Preliminary.)
It has no human trial evidence of clinical benefit. (Absent.)
Its demulcent effect is not distinctive — it is a property shared with several safe herbs, at least one of which has a higher mucilage content.
It carries a documented, mechanistically established, cumulative liver hazard that those alternatives do not. (Established.)

That is not a close decision, and it is not a close decision for an unusual reason: the case against coltsfoot does not depend on the herb being useless. It could be modestly useful and the conclusion would not change, because the same modest usefulness is available from marshmallow root, mullein, thyme or honey at no hepatic cost. Safer Alternatives to Coltsfoot for Cough works through those options at their real evidence tiers.

When a Cough Needs a Clinician

No herb on this site is a substitute for assessment when a cough carries warning features. Seek medical attention for:

Cough lasting more than about three weeks, or worsening rather than settling.
Coughing up blood.
Breathlessness at rest or on mild exertion, or wheeze that is new.
Chest pain, especially with breathing.
Persistent or high fever, drenching night sweats, or unintended weight loss.
Cough in an infant, or a barking or whooping quality in a child.
Cough with ankle swelling or on lying flat, which can be cardiac.
Any cough in someone with known lung disease that changes character — see Asthma, Bronchitis and Chronic Cough.

Evidence Tiers for Every Claim

Coltsfoot was used for cough for two millennia in Europe and China — documented historical record.
Classical authors recommended smoking the leaf — documented historical record.
Kuan dong hua is used, usually honey-fried and in formula, for cough and wheezing — traditional use only.
Coltsfoot contains mucilage and acts as a demulcent — established chemistry; demulcent mechanism established as a class effect.
Sugar syrup and honey reduce cough via a pharyngeal/reflex mechanism — established, with trial evidence for honey.
Tussilagone is anti-inflammatory via heme oxygenase-1 induction — preliminary, cell study.
Coltsfoot extract reduces induced cough in animals — preliminary, animal models.
Coltsfoot relieves cough in humans better than placebo — not demonstrated; no adequate trial exists.
Coltsfoot is safe for internal use — contradicted. See the liver-risk page.

Key Research Papers

Each link runs a live PubMed topic search rather than pointing at a single record.

A review of the ethnobotanical value, phytochemistry, pharmacology, toxicity and quality control of Tussilago farfara L. (coltsfoot), Journal of Ethnopharmacology, 2021 — the best single starting point for the plant's traditional uses, chemistry and toxicity together. Search PubMed
The anti-inflammatory effect of tussilagone, from Tussilago farfara, is mediated by the induction of heme oxygenase-1 in murine macrophages, International Immunopharmacology, 2009 — the mechanism behind coltsfoot's anti-inflammatory laboratory profile. Search PubMed
Pharmacological studies of tussilagone as a cardiovascular and respiratory stimulant isolated from Tussilago farfara — the older animal pharmacology, including its pressor action. Search PubMed
Reported platelet-activating-factor antagonism by tussilagone — relevant to airway inflammation in laboratory models. Search PubMed
Antitussive and expectorant evaluation of Tussilago farfara extracts in animal cough models — the preliminary efficacy literature and its limitations. Search PubMed
Sesquiterpenoids and other constituents isolated from Tussilago farfara flower buds — the phytochemistry underlying kuan dong hua. Search PubMed
Demulcent and mucilage polysaccharides in the management of dry cough — the class mechanism coltsfoot shares with marshmallow and mullein. Search PubMed
The role of sweet, viscous vehicles and the placebo response in antitussive trials — why syrup arms perform well and why uncontrolled impressions mislead. Search PubMed
Natural history and duration of acute cough after upper respiratory infection — the untreated trajectory any remedy is compared against. Search PubMed
Honey for acute cough in children — the best-evidenced simple comparator, with randomised trials and systematic reviews. Search PubMed
Ivy leaf (Hedera helix) extract in acute bronchitis and productive cough — a traditional cough herb that has been trialled. Search PubMed
Pelargonium sidoides extract for acute respiratory infection and bronchitis — randomised trial and review evidence. Search PubMed
Thyme and primrose root combination for acute bronchitis — randomised evidence for a licensed European herbal combination. Search PubMed
Pyrrolizidine alkaloids in Tussilago farfara and the resulting safety assessment — the reason the tradition cannot be acted on directly. Search PubMed

External Resources

Cochrane Library — systematic reviews of cough treatments, including honey and over-the-counter preparations.
European Medicines Agency — herbal monographs, including the traditional-use assessments granted to other cough herbs.
NIH National Center for Complementary and Integrative Health — plain-language herb summaries.
PubMed — the literature database behind every citation above.

Connections

Safety Note and Disclaimer

This page documents a traditional use and the evidence for it; it is not a recommendation. Coltsfoot contains hepatotoxic pyrrolizidine alkaloids, and no cough benefit described here has been shown in a controlled human trial. This site's honest reading is that internal coltsfoot should be avoided, because the same soothing effect is available from herbs that carry no liver risk. Do not take coltsfoot if you are pregnant or breastfeeding, do not give it to a child, and do not take it if you have any liver condition, drink heavily or take prescription medicines. Never give honey to an infant under twelve months. This information is educational and does not replace personal medical advice; a cough with any of the warning features listed above needs a clinician.

Back to Table of Contents